story of the week
Adjuvant Nivolumab in Resected Esophageal or Gastroesophageal Junction Cancer
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
The New England Journal of Medicine
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Adjuvant Nivolumab in Resected Esophageal or Gastroesophageal Junction Cancer
N. Engl. J. Med 2021 Apr 01;384(13)1191-1203, RJ Kelly, JA Ajani, J Kuzdzal, T Zander, E Van Cutsem, G Piessen, G Mendez, J Feliciano, S Motoyama, A Lièvre, H Uronis, E Elimova, C Grootscholten, K Geboes, S Zafar, S Snow, AH Ko, K Feeney, M Schenker, P Kocon, J Zhang, L Zhu, M Lei, P Singh, K Kondo, JM Cleary, M MoehlerFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.